Here are some updates and changes happening on the GeM Portal between May 2024 and December 2024: 1. **Technical Overhaul**: The GeM portal will undergo a major technical overhaul, making it temporarily unavailable from **00:00 hrs of 27th November 2024 to 23:59 hrs of 5th December 2024**. 2. **Scheduled Maintenance**: Periodic scheduled maintenance will be conducted to improve system performance and security | National Public Procurement Portal ...](https://gem.gov.in/). 3. **Policy Updates**: Amendments in procurement policies and financial rules may be implemented | National Public Procurement Portal ...](https://gem.gov.in/). 4. **New Features**: Introduction of new features and functionalities to enhance user experience and streamline the procurement process | National Public Procurement Portal ...](https://gem.gov.in/). 5. **Notification Delays**: Users might experience receiving email and SMS notifications delays due to system updates | National Public Procurement Portal .....
The Government e-marketplace (GeM) offers significant opportunities for businesses in the pharma sector to secure government contracts through tenders. Participation in GeM tenders can be highly profitable due to the platform's broad reach and the diversity of contracts available. For instance, various goods and services, including pharmaceuticals, are procured through GeM, ensuring a continuous demand from numerous government departments and public sector undertakings.
# Earnings Potential in the Pharma Sector via GeM
1. **High Procurement Volumes**: Government agencies and departments regularly procure a wide range of pharmaceutical products, making the sector one of the key beneficiaries of the GeM platform. For example, SECL procured goods and services worth more than ₹346 crores through GeM in the current financial year(PSU Watch)..
2. **Competitive Bidding**: The platform promotes competitive bidding, which can lead to significant earnings if a business can offer competitive pricing while maintaining quality. This process ensures that even small and medium enterprises (SMEs) have a fair chance to win contracts(Centre for Public Impact).
3. **Increased Visibility and Market Access**: By participating in GeM tenders, pharma companies can increase their visibility and access a larger market within the government procurement system. This can lead to sustainable business growth over time (Gem Portal) (Centre for Public Impact).
#Costs and Tender Values
1. **Tender Values**: The value of tenders can vary greatly depending on the product or service type. High-value tenders, such as those for extensive medical supplies or specialized pharmaceutical products, can run into several crores. For instance, a tender worth ₹2,063 crore was issued by SECL for mining services, indicating the scale at which government tenders can operate(PSU Watch).
2. **Cost of Participation**: The cost associated with participating in GeM tenders typically includes the cost of bid preparation, which may involve document preparation, compliance checks, and sometimes a nominal fee for bid submission. However, the platform itself is designed to be cost-effective, particularly benefiting SMEs through simplified processes and reduced administrative overhead (Gem Portal).
# Key Considerations for Pharma Companies
1. **Eligibility and Compliance**: Pharma companies must ensure they meet all eligibility criteria and comply with the documentation requirements outlined in the tender documents. This includes registration on the GeM portal, which is a straightforward process but requires attention to detail (Gem Portal).
2. **Strategic Bidding**: Companies need to craft compelling bids that meet buyer requirements while being competitively priced. Understanding the nuances of the bidding process, including reverse auctions and e-bidding, can significantly enhance the chances of winning tenders (Gem Portal).
Overall, the GeM portal provides a lucrative opportunity for pharma companies to expand their business through government contracts. By leveraging the platform's transparency and efficiency, businesses can achieve substantial growth and secure significant earnings from government procurement (Centre for Public Impact) (PSU Watch).
Earning potential in the pharmaceutical industry through the Government e-Marketplace (GeM) portal can be substantial, depending on various factors such as the volume of tenders won, the value of those tenders, and the company's ability to deliver competitively priced and high-quality products.
# Key Factors Influencing Earnings
1. **Volume of Tenders**: The more tenders a pharmaceutical company participates in and wins, the higher the potential earnings. Companies can bid for a wide range of products, from basic medicines to specialized pharmaceutical supplies.
2. **Value of Tenders**: The value of individual tenders can vary significantly. For instance, SECL (South Eastern Coalfields Limited) issued tenders worth more than ₹2,063 crore for services through the GeM portal, highlighting the potential high value of government contracts【9†source】.
3. **Competitive Pricing and Quality**: Successful bidding often depends on offering competitive prices while maintaining high product quality. Government agencies prioritize cost-efficiency and quality, which means companies need to balance these aspects effectively.
### Case Studies and Examples
1. **SECL Procurement**: In the current financial year, SECL procured goods and services worth over ₹346 crores through the GeM portal. This includes significant purchases of pharmaceuticals and other medical supplies, demonstrating the substantial procurement volumes possible (PSU Watch).
2. **General Savings and Efficiency**: The GeM platform has been instrumental in achieving up to 25% savings in government expenditure on procurement, which implies that the platform facilitates significant procurement activities across various sectors, including pharmaceuticals (Centre for Public Impact)..
### Potential Earnings Estimate
Given the examples and the nature of procurement through GeM, a pharmaceutical company can potentially earn from a few lakhs to several crores annually, depending on its ability to secure tenders. High-value contracts and consistent participation in the bidding process can lead to substantial earnings.
For example, if a company secures multiple tenders amounting to ₹10 crores in a year, with an average profit margin of 10%, the earnings would be around ₹1 crore. Companies with more extensive operations and higher bid success rates could see much higher earnings.
### Conclusion
The pharmaceutical industry has significant earning potential through the GeM portal, with opportunities ranging from small contracts for basic supplies to large-scale tenders for specialized pharmaceutical products. By leveraging the platform's transparent and efficient procurement process, pharmaceutical companies can achieve substantial growth and secure significant earnings (Gem Portal) (PSU Watch).
Comments